Alterations in apolipoprotein E expression during aging and neurodegeneration

Progress in Neurobiology

Volumn 50, Issue 5-6, 1996, Pages 493-503

  Masliah, Eliezer ^a,b   Mallory, Margaret ^a   Veinbergs, Isaac ^a   Miller, Aida ^a   Samuel, William ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR;

AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; CENTRAL NERVOUS SYSTEM; CHOLESTEROL TRANSPORT; CYTOSKELETON; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LIPID METABOLISM; MOUSE; NERVE CELL; NERVE CELL DEGENERATION; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYNAPSE;

EID: 0030464403     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(96)00038-X     Document Type: Article

References (80)

1. Akaaboune, M., Villanova, M., Festoff, B. W., Verdiere-Sahuque, M. and Hantai, D. (1994) Apolipoprotein E expression at neuromuscular junctions in mouse, rat and human skeletal muscle. FEBS Lett. 351, 246-248.
2. Andersson, P.-B., Perry, V. H. and Gordon, S. (1991) The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience 42, 210-214.
3. Arai, Y., Mizuguchi, M., Ikeda, K. and Takashima, S. (1995) Developmental changes of apolipoprotein E immunoreactivity in Down syndrome brains. Brain Res. Dev. Brain Res. 87, 228-232.
4. Balcar, V. J. and Li, Y. (1992) Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system. Life Sci. 51, 1467-1478.
5. Benzing, W. C. and Mufson, E. J. (1995) Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease. Expl Neurol. 132, 162-171.
6. Bertrand, P., Poirier, J., Oda, T., Finch, C. E. and Pasinetti, C. M. (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer's disease. Mol. Brain Res. 33, 174-178.
7. Bifulco, M., Laezza, C., Aloj, S. M. and Garbi, C. (1993) Mevalonate controls cytoskeleton organization and cell morphology in thyroid epithelial cells. J. Cell. Physiol. 155, 340-348.
8. Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W. and Taylor, J. M. (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76, 1501-1513.
9. Boyles, J. K., Notterpek, L. M. and Anderson, L. J. (1990) Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. J. Biol. Chem. 265, 17805-17815.
10. Chou, S. C., Cheng, B. and Kowal, J. (1995) Aging in rats is associated with an increase in adrenal apolipoprotein E. Molec. Cell. Endocrin. 107, 93-97.
11. Diedrich, J. F., Minnigan, H., Carp, R. I., Whitaker, J. N., Race, R., Frey, W. II and Haase, A. T. (1991) Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65, 4759-4768.
12. Elshourbagy, N. A., Liao, W. S., Mahley, R. W. and Taylor, J. M. (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. natn. Acad. Sci. U.S.A. 82, 203-207.
13. Finch, C. E., Laping, N. J., Morgan, T. E., Nichols, N. R. and Pasinetti, G. M. (1993) TGF-beta 1 is an organizer of responses to neurodegeneration [see comments]. J. Cell Biochem. 53, 314-322.
14. Gandy, S., Stafstrom, C., Turner, B., Sweeney, D., Breslow, J., Greengard, P., Smith, J. and Quimet, C. (1995) Aged apoE-deficient mice: abnormal learning and glial markers but no obvious neuropathology. Soc. Neurosci. Abstr. 21, 5.
15. 3H] kaininc acid-binding sites in the central nervous system of the developing mouse: an autoradiographic study. Neurosci. Lett. 151, 209-213.
16. Gearing, M., Rebeck, G. W., Hyman, B. T., Tigges, J. and Mirra, S. S. (1994) Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 91, 9382-9386.
17. Genis, I., Gordon, I., Sehayek, E. and Michaelson, D. M. (1995) Phosphorylation of tau in apolipoprotein E-deficient mice. Neurosci. Lett. 199, 5-8.
18. Goedert, M., Crowther, R. A. and Garner, C. C. (1991) Molecular characterization of microtubule-associated proteins tau and MAP2. Trends Neurosci. 14, 193-199.
19. Gordon, I., Grauer, E., Genis, I., Sehayek, E. and Michaelson, D. M. (1995) Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199, 1-4.
20. Greenamyre, J. T. and Porter, R. H. P. (1994) Anatomy and physiology of glutamate in the CNS. Neurology 44, suppl, S7-S13.
21. 4 in humans. J. Clin. Invest. 78, 815-821.
22. Gundersen, G. G., Kim, I. and Chapin, C. J. (1994) Induction of stable microtubules in 3T3 fibroblasts by TGF-β and serum. J. Cell Sci. 107, 645-659.
23. Hall, Z. W. (1992) An Introduction to Molecular Neurobiology. Sinauer Associates, Inc.: Sunderland.
24. Han, S.-H., Einstein, G., Weisgraber, K. H., Strittmatter, W. J., Saunders, A. M., Vance-Pericak, M., Roses, A. D. and Schmechel, D. E. (1994a) Apolipoprotein E is localized to the cytoplasm of human cortical neurons. A light and electron microscopic study. J. Neuropathol. expl Neurol. 53, 535-544.
25. Han, S.-H., Hulette, C., Saunders, A. M., Einstein, G., Pericak-Vance, M., Strittmatter, W. J., Roses, A. D. and Schmechel, D. E. (1994b) Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Expl Neurol. 128, 13-26.
26. Handelmann, G. E., Boyles, J. K., Weisgraber, K. H., Mahley, R. W. and Pitas, R. E. (1992) Effects of apolipoprotein E, β-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J. Lipid Res. 33, 1677-1688.
27. Hartmann, H., Eckert, A. and Muller, W. E. (1994) Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity. Biochem. Biophys. Res. Commun. 200, 1185-1192.
28. Holtzman, D. M., Pitas, R. E., Kilbridge, J., Nathan, B., Mahley, R. W., Bu, G. and Schwartz, A. L. (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. natn. Acad. Sci. U.S.A. 92, 9480-9484.
29. Huang, D. Y., Goedert, M., Jakes, R., Weisgraber, K. H., Garner, C. C., Saunders, A. M., Pericak-Vance, M. A., Schmechel, D. E., Roses, A. D. and Strittmatter, W. J. (1994) Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease. Neurosci. Lett. 182, 55-58.
30. Huang, D. Y., Weisgraber, K. H., Strittmatter, W. J. and Matthew, W. D. (1995) Interaction of apolipoprotein E within laminin increases neuronal adhesion and alters neurite morphology. Expl Neurol. 136, 251-257.
31. Iacopino, A. M. and Christakos, S. (1990) Specific reduction of calcium-binding protein (28 kDa calbindin-D) gene expression in aging and neurodegenerative diseases. Proc. natn. Acad. Sci. U.S.A. 87, 4078-4082.
32. Ignatius, M. J., Shooter, E. M., Pitas, R. E. and Mahley, R. W. (1987) Lipoprotein uptake by neuronal growth cones in vitro. Science 236, 959-962.
33. Ito, J., Masuda, M. and Tanaka, R. (1994) Sialosylcholesterol effects on reconstitution of microfilament and glia filament. J. Neurochem. 62, 235-239.
34. Kanai, Y., Smith, C. P. and Hediger, M. A. (1993) The elusive transporters with a high affinity for glutamate. Trends Neurosci. 16, 359-365.
35. Kanai, Y., Stelzner, M., Nubberg, S., Khawaja, S., Hebert, S. C., Smith, C. P. and Hediger, M. A. (1994) The neuronal and epithelial human high affinity glutamate transporter. J. Biol. Chem. 269, 20599-20606.
36. Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argaves, W. S., Tanzi, R. E., Hyman, B. T. and Strickland, D. K. (1995) LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82, 331-340.
37. Lenich, C., Brecher, P., Makrides, S., Chobanian, A. and Zannis, V. I. (1988) Apolipoprotein gene expression in the rabbit: abundance, size and distribution of apolipoprotein mRNA species in different tissues. J. Lipid Res. 29, 755-764.
38. Lin-Lee, Y. C., Kao, F. T., Cheung, P. and Chan, L. (1985) Apolipoprotein E gene mapping and expression: localization of the structural gene to human chromosome 19 and expression of ApoE mRNA in lipoprotein-and non-lipoprotein-producing tissues. Biochemistry 24, 3751-3756.
39. Ludes, B., Schmit, A. C., Cremel, G., Lambert, A. M., Hubert, P., Jacqmin, D., Bollack, C. and Staedel, C. (1993) Influence of cholesterol derivatives on cytoskeletal organization of human carcinoma cells. Eur. Urol. 23, 490-501.
40. Mahley, R. W. and Innerarity, T. L. (1983) Lipoprotein receptors and cholesterol homeostasis. Biochim. Biophys. Acta 737, 197-222.
41. Masliah, E., Pagan, A. M., Terry, R. D., DeTeresa, R., Mallory, M. and Gage, F. H. (1991) Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Expl Neurol. 113, 131-142.
42. Masliah, E., Mallory, M., Alford, M. and Mucke, L. (1994) Abnormal synaptic regeneration in hAPP transgenic and APOE-knockout mice. Neurobiol. Aging 15, S11.
43. Masliah, E., Mallory, M., Alford, M., Veinbergs, I. and Roses, A. D. (1995a) ApoE role in maintaining the integrity of the aging central nervous system. In: Apolipoprotein E and Alzheimer's Disease. Eds Y. Christen and A. D. Roses. Springer-Verlag: New York.
44. Masliah, E., Mallory, M., Ge, N., Alford, M., Veinbergs, I. and Roses, A. D. (1995b) Neurodegeneration in the CNS of apoE-deficient mice. Expl Neurol. 136, 107-122.
45. Masliah, E., Mallory, M., Alford, M., Ge, N. and Mucke, L. (1995c) Abnormal synaptic regeneration in hAPP695 transgenic and APOE knockout mice. In: Research Advances in Alzheimer's Disease and Related Disorders, pp. 405-414. Eds K. Iqbal, J. A. Mortimer, B. Winblad and H. M. Wisniewski. John Wiley and Sons: New York.
46. Masliah, E., Samuel, W., Veinbergs, I., Mallory, M., Mante, M. and Saitoh, T. (1996) Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Society for Neuroscience Abstracts 22, 207.
47. Matthews, D. A., Cotman, C. and Lynch, G. (1976) An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. II. Reappearance of morphologically normal synaptic contacts. Brain Res. 115, 23-41.
48. Mattson, M. P., Cheng, B., Culwell, A. R., Esch, F. S., Lieberburg, I. and Rydel, R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10, 243-254.
49. McKee, A. C., Kosik, K. S. and Kowall, N. W. (1991) Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30, 156-165.
50. Michaelis, M. L., Foster, C. T. and Jayawickreme, C. (1992) Regulation of calcium levels in brain tissue from adult and aged rats. Mech. Ageing Dev. 62, 291-306.
51. Miller, A., Alford, M., Katzman, R., Thai, L. and Masliah, E. (1994) The expression of the ApoE4 allele in Alzheimer's disease accentuates the synaptic loss and the severity of the dementia. Ann. Neurol. 36, 268.
52. Mucke, L., Masliah, E., Johnson, W. B., Ruppe, M. D., Rockenstein, E. M., Forss-Petter, S., Pietropaolo, M., Mallory, M. and Abraham, C. R. (1994) Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res. 666, 151-167.
53. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E. and Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166.
54. Namba, Y., Tsuchiya, H. and Ikeda, K. (1992) Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease. Neurosci. Lett. 134, 264-266.
55. Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W. and Pitas, R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852.
56. Paik, Y.-K., Chang, D. J., Reardon, C. A., Davies, G. E., Mahley, R. W. and Taylor, J. M. (1985) Nucleotide sequence and structure of the human apolipoprotein E gene. Proc. natn. Acad. Sci. U.S.A. 82, 3445-3449.
57. Pitas, R. E., Innerarity, T. L., Weinstein, J. N. and Mahley, R. W. (1981) Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis 1, 177-185.
58. Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D. and Mahley, R. W. (1987) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochem. Biophys. Res. Commun. 917, 148-161.
59. Poirier, J., Hess, M., May, P. C. and Finch, C. E. (1991) Apolipoprotein E and GFAP-RNA in hippocampus during reactive synaptogenesis and terminal proliferation. Molec. Brain Res. 11, 97-106.
60. Poirier, J., Baccichet, A., Dea, D. and Gauthier, S. (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodeling in hippocampus in adult rats. Neuroscience 55, 81-90.
61. Poirier, J. (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17, 525-530.
62. Poirier, J., Delisle, M.-C, Quirion, R., Aubert, I., Farlow, M., Lahiri, D., Hui, S., Bertrand, P., Nalbantoglu, J., Gilfix, B. M. and Gauthier, S. (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 92, 12260-12264.
63. Popko, B., Goodrum, J. F., Bouldin, T. W., Zhang, S. H. and Maeda, N. (1993) Nerve regeneration occurs in the absence of apolipoprotein E in mice. J. Neurochem. 60, 1155-1158.
64. Rebeck, G. W., Reiter, J. S., Strickland, D. K. and Hyman, B. T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580.
65. Roses, A. D., Einstein, G., Gilbert, J., Goedert, M., Han, S.-H., Huang, D., Hulette, C., Masliah, E., Pericak-Vance, M. A., Saunders, A. M., Schmechel, D. E., Strittmatter, W. J., Weisgraber, K. H. and Xi, P.-T. (1996) Morphological, biochemical, and genetic support for an apolipoprotein E effect on microtubular metabolism. Ann. NY Acad. Sci. 777, 147-157.
66. Saunders, A. M., Strittmatter, W. J., Schmechel, D., St George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Hulette, C., Crain, B., Goldgaber, D. and Roses, A. D. (1993) Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
67. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D. and Roses, A. D. (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 90, 9649-9653.
68. Sparks, D. L., Liu, H., Gross, D. R. and Scheff, S. W. (1995) Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol. Neurosci. Lett. 187, 142-144.
69. Strain, S. M. and Tasker, R. A. R. (1991) Hippocampal damage produced by systemic injections of domoic acid in mice. Neuroscience 44, 343-352.
70. Strickland, D. K., Kounas, M. Z. and Argaves, W. S. (1995) LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 9, 890-898.
71. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S. and Roses, A. D. (1993a) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 90, 1977-1981.
72. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D. and Roses, A. D. (1993b) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 90, 8098-8102.
73. Strittmatter, W. J., Weisgraber, K. H., Goedert, M., Saunders, A. M., Huang, D., Corder, E. H., Dong, L. M., Jakes, R., Alberts, M. J. and Gilbert, J. R. (1994) Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Expl Neurol. 125, 163-171.
74. Terry, R. D., Hansen, L. and Masliah, E. (1994) Structural alterations in Alzheimer disease. In: Alzheimer's Disease, pp. 179-196. Eds R. D. Terry and R. Katzman. Raven Press: New York.
75. Urca, G. and Urca, R. (1990) Neurotoxic effects of excitatory amino acids in the mouse spinal cord: quisqualate and kainate but not N-methyl-D-aspartate induced permanent neural damage. Brain Res. 529, 7-15.
76. Vance, J. E., Pan, D., Campenot, R. B., Bussiere, M. and Vance, D. E. (1994) Evidence that the major membrane, lipids, except cholesterol, are made in axons of cultured rat sympathetic neurons. J. Neurochem. 62, 329-337.
77. Wyss-Coray, T., Feng, L., Masliah, E., Ruppe, M. D., Toggas, S. M., Rockenstein, E. M. and Mucke, L. (1995) Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor β1. Am. J. Pathol. 147, 53-67.
78. Yamada, T., Kondo, A., Takamatsu, J., Tateishi, J. and Goto, I. (1995) Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease. J. Neurol. Sci. 129, 56-61.
79. Zannis, V. L. and Breslow, J. L. (1981) Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochem. 20, 1033-1041.
80. Zuckerman, S. H., Evans, G. F. and O'Neal, L. (1992) Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-β. Atherosclerosis 96, 203-214.